Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Transplant. Mar 18, 2025; 15(1): 98975
Published online Mar 18, 2025. doi: 10.5500/wjt.v15.i1.98975
Table 1 Patients’ characteristics at intensive care unit admission, n (%)/median (25th-75th percentiles)

Total population (n = 91)
SOT (n = 28)
HSCT (n = 63)
χ²
P value
Age at admission (years)56 (43.2-64.7)61 (51.5-68)54 (40.5-61)NA< 0.01
Age at transplantation (years)50 (36.2-59)50 (36.7-58.2)51 (35-60)NA0.86
Male gender55 (60.4)17 (60.7)38 (60.3)0.0010.97
Comorbidities
Cardiovascular56 (61.5)26 (92.9)30 (47.6)16.76< 0.01
Respiratory13 (14.3)3 (10.7)10 (15.9)NA0.51
Chronic kidney disease34 (37.4)26 (92.9)8 (12.7)53.22< 0.01
Chronic hemodialysis11 (12.1)9 (32.1)2 (3.2)NA< 0.01
Diabetes16 (17.6)7 (25)9 (14.3)1.530.21
Malignant disease11 (12.1)4 (14.3)7 (11.1)NA0.70
Disease severity
SOFA 9 (6-11)7.5 (5-11)9 (7-10)NA0.37
APACHE II 22 (17.5-27)19 (14-22)23 (19-27)NA0.01
Respiratory support48 (52.7)12 (42.9)36 (57.1)1.580.20
Vasoactive medication support32 (35.2)9 (32.1)23 (36.5)0.160.68